MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases

H. Schmitz-Peiffer, K. Linse, W. Rüger, M. Joos, M. Löhle, A. Storch, A. Hermann (Dresden, Germany)

Meeting: 2016 International Congress

Abstract Number: 1435

Keywords: Cognitive dysfunction, Eye movement, Motoneuron disease, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Cognition

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To develop and evaluate motor-free procedures via eye tracking for determining cognitive functions in patients with idiopathic Parkinson’s disease (PD) and motor neuron disease (MND).

Background: Many recognized measurements and survey methods to study cognitive functions are based on written/oral in-/output. As a result, the assessment of patients with advanced neurodegenerative diseases such as PD and MND is often limited due to motor impairments.

Methods: We implemented an established "paper-pencil" test (Trail Making Test, Raitan, 1979) for measuring attention (TMT-A) and executive functions (TMT-B) in a special eye tracking software (eTMT). Precision and performance results of PD and MND patients as well as healthy controls (C) were evaluated. Patients were dichotomized either according to above- and below-average ALSFRS-R scores (MND+/MND-) or Hoehn & Yahr scores (≥3: PD-/<3: PD+), respectively. Age, education, wellbeing and personality were assessed as control variables.

Results: 21 subjects with PD, 28 subjects with MNDs and 18 control subjects completed the assessment. 11 severely affected ALS patients (ALS-) were unable to perform the written TMT. Demographic analyses only revealed slight age differences (p.047). Among all groups, the obtained fixation data neither revealed differences in accuracy (p=.06) nor in the relevant eTMT processing times (eTMT-A: p=.31; eTMT-B: p=.09). The age-corrected partial correlations between the TMT-A and eTMT-A (r=.369, p=.05) as well as the TMT-B and eTMT-B (r=.631, p<.001) were significant across all subjects. Differences between subgroups became apparent in the number of fixations per second and written TMT processing times.

Conclusions: The results confirm a high accuracy of the method and indicate a sufficient overlap of each assessed construct. Thus, eye tracking is suitable for the measurement of cognitive performance in patients with neurodegenerative diseases and motor restrictions.

DGN 2015, Duesseldorf, Germany.

To cite this abstract in AMA style:

H. Schmitz-Peiffer, K. Linse, W. Rüger, M. Joos, M. Löhle, A. Storch, A. Hermann. Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/eye-tracking-based-measurement-of-cognitive-functions-in-patients-with-neurodegenerative-diseases/. Accessed July 4, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/eye-tracking-based-measurement-of-cognitive-functions-in-patients-with-neurodegenerative-diseases/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley